Molecular changes in thyroid neoplasia.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Thyroid cancer comprises distinct histotypes with unique molecular underpinnings.
• Understanding these differences is crucial for targeted therapies and prognostication.

Purpose of the Study:

• To delineate the distinct molecular pathways of papillary and follicular thyroid carcinogenesis.
• To investigate the role of specific genetic alterations in thyroid cancer development and progression.

Main Methods:

• Comparative analysis of genetic alterations (RET rearrangements, RAS mutations, P53 mutations, DNA methylation, aneuploidy) in papillary and follicular thyroid cancers.
• Evaluation of tumor suppressor gene (P16, P53) alterations and chromosomal instability markers.

Main Results:

• RET rearrangements are initiating events in papillary thyroid carcinoma, while RAS mutations are critical in follicular adenomas and contribute to papillary cancer progression.
• Aberrant DNA methylation affecting the P16 tumor suppressor gene is common in both types.
• Follicular cancers show higher aneuploidy rates, whereas papillary cancers have lower rates of loss of heterozygosity and microsatellite instability.
• P53 mutations are associated with undifferentiated thyroid cancers and aggressive phenotypes.
• RET/PTC3 mutations were frequently observed in sporadic papillary thyroid carcinoma in Polish children, challenging the hypothesis of RET rearrangements as specific markers for radiation-induced thyroid cancer.

Conclusions:

• Papillary and follicular thyroid cancers follow divergent molecular routes.
• Specific genetic mutations and chromosomal abnormalities characterize each histotype.
• RET rearrangements may not be exclusive markers for radiation-induced pediatric thyroid cancer.